Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance
Elevance Health stock fell 7-9% despite beating Q2 estimates and raising guidance, as margins declined year-over-year.
Read the full articleYou might also wanna read
Elevance Health Inc (ELV) Stock Down 8.5% -- Now Undervalued? GF Score: 88/100
Related Stocks: ELV
UnitedHealth Group (NYSE:UNH) says at least 84% of its Q2 beat is now in its outlook; Elevance Health (NYSE:ELV) moved 20%
NEW YORK, July 16, 2026, 06:23 EDT UnitedHealth bumped up the lower end of its 2026 adjusted EPS outlook by $1.25 after topping second-quart
UnitedHealth (UNH) Stock Slides Before Thursday’s Q2 Earnings Report
UnitedHealth (UNH) stock drops ahead of Thursday's Q2 earnings. Analysts expect $4.85 EPS, $110.77B revenue. Buy rating with $432.63 target
Elevance Health (ELV) Q2 2026 Earnings Call Transcript
CEO Boudreaux raised full-year guidance after beating Q2 projections.
UnitedHealth Stock Update: Q2 Earnings Beat and AI Strategy Explained
UnitedHealth beat Q2 2026 earnings estimates, raised full-year guidance and highlighted its $3 billion AI strategy as improved cost controls
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
NEW YORK, July 12, 2026, 4:33 p.m. EDT — Healthcare stocks head into the week with Johnson & Johnson, UnitedHealth and Abbott set to gauge w
Comments
Sign in to join the conversation.
No comments yet. Be the first.